Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Needle Bleb Revision With Ranibizumab as a Primary Intervention in a Failing Bleb Following Trabeculectomy

NCT00570726 is registered in ClinicalTrials.gov with The New York Eye & Ear Infirmary as lead sponsor.

NCT NCT00570726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00570726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Needle Bleb Revision With Ranibizumab as a Primary Intervention in a Failing Bleb Following Trabeculectomy
Lead sponsor
The New York Eye & Ear Infirmary
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2000
Completion date
November 30, 2007
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

failing bleb following trabeculectomy, glaucoma, open-angle